Abstract

Lacticaseibacillus rhamnosus GG is one of the best studied lactic acid bacteria in the context of probiotic effects. L. rhamnosus GG has been shown to prevent diarrhea in children and adults and has been implicated to have mitigating or preventive effects in several disorders connected to microbiota dysbiosis. The probiotic effects are largely attributed to its adhesive heterotrimeric sortase-dependent pili, encoded by the spaCBA-srtC1 gene cluster. Indeed, the strain-specific SpaCBA pili have been shown to contribute to adherence, biofilm formation and host signaling. In this work we set out to generate non-GMO derivatives of L. rhamnosus GG that adhere stronger to mucus compared to the wild-type strain using chemical mutagenesis. We selected 13 derivatives that showed an increased mucus-adherent phenotype. Deep shotgun resequencing of the strains enabled division of the strains into three classes, two of which revealed SNPs (single nucleotide polymorphisms) in the spaA and spaC genes encoding the shaft and tip adhesive pilins, respectively. Strikingly, the other class derivatives demonstrated less clear genotype – phenotype relationships, illustrating that pili biogenesis and structure is also affected by other processes. Further characterization of the different classes of derivatives was performed by PacBio SMRT sequencing and RNAseq analysis, which resulted in the identification of molecular candidates driving pilin biosynthesis and functionality. In conclusion, we report on the generation and characterization of three classes of strongly adherent L. rhamnosus GG derivatives that show an increase in adhesion to mucus. These are of special interest as they provide a window on processes and genes driving piliation and its control in L. rhamnosus GG and offer a variety of non-GMO derivatives of this key probiotic strain that are applicable in food products.

Highlights

  • The last decade of microbiome analysis has rendered a plethora of information on the bacteria inhabiting a healthy or diseased microbiota-gut ecosystem

  • The aim of the present study was to decipher whether it would be possible to produce highly mucus-adherent derivatives of L. rhamnosus GG using random mutagenesis induced by the chemical mutagen ethyl methanesulfonate

  • By coating a plate with anti-SpaC IgG we aimed to enrich derivatives that presented a higher fraction of SpaC pilins, the major adhesive pilin of the L. rhamnosus GG SpaCBA pili, on their cell surface

Read more

Summary

Introduction

The last decade of microbiome analysis has rendered a plethora of information on the bacteria inhabiting a healthy or diseased microbiota-gut ecosystem. Dysbiosis of the gut microbiota has been correlated to a large variety of non-communicable diseases, like diabetes, obesity and even autism (Qin et al, 2010) Building further on this knowledge, it is key to support these correlations with hard-core microbiology insights: understanding how bacteria can mediate and influence human physiology. Many of the most widely studied probiotics are lactic acid bacteria, with Lacticaseibacillus rhamnosus GG being a prime example (de Vos, 2011). This strain was previously known as Lactobacillus rhamnosus GG (Zheng et al, 2020). As demanded by EFSA (European Food Safety Authority), health claims should be corroborated by defined studies of probiotic effectors (Binnendijk and Rijkers, 2013)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call